Lv4
510 积分 2023-04-20 加入
Dotinurad: a novel selective urate reabsorption inhibitor as a future therapeutic option for hyperuricemia
6小时前
待确认
Effects of mild and moderate renal dysfunction on pharmacokinetics, pharmacodynamics, and safety of dotinurad: a novel selective urate reabsorption inhibitor
6小时前
已完结
Open-label study of long-term administration of dotinurad in Japanese hyperuricemic patients with or without gout
6小时前
已完结
A clinical pharmacology study of the novel, selective urate reabsorption inhibitor dotinurad in outpatients
6小时前
已完结
Dotinurad: a novel selective urate reabsorption inhibitor for the treatment of hyperuricemia and gout
6小时前
已完结
Comparative efficacy and safety of dotinurad, febuxostat, and benzbromarone in hyperuricemic patients with or without gout: A network meta-analysis of randomized controlled trials
6小时前
已完结
Comparative efficacy and safety of uricosuric agents in the treatment of gout or hyperuricemia: a systematic review and network meta-analysis
6小时前
待确认
Changes in Urinary Uric Acid Concentration after Dotinurad Administration to Patients with Hyperuricemia: A Post Hoc Analysis of Two Clinical Trials in Japan
6小时前
已完结
Pipeline Therapies for Gout
6小时前
已完结
皖公网安备34019202002308
